Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Public Relations; Health Care
Companies Profiled:
Abbvie; Adamas Pharmaceuticals; AstraZeneca; Biogen; Bayer; Catalyst Pharmaceuticals; FleishmanHillard; Fresenius Medical Care AG & Co. KGaA; Genzyme; Indivior; Lilly; Merck; Novartis; Prometheus Therapeutics & Diagnostics; Tokai Pharmaceuticals; Vertex Pharmaceuticals; ZS Pharma
                  
                  
                  
Table of Contents
·	Executive Summary, pgs. 4-8	
ü	Research Overview, pg. 4
ü	Participating Companies, pg. 5
ü	Key Findings Overview, pg. 6
ü	Key Insights Overview, pg. 7
ü	Overview of DA Timing, pgs. 8
I. Participant Demographics, pgs. 9-13 
II. Program Effectiveness and Structure, pgs. 14-19
III. Timing of Disease Awareness Activities, pgs. 20-27
IV.  Disease Awareness Budget and Spend, pgs. 28-36
V.  Involvement of Advocacy and Legal, pgs. 37-45
VI. Social Media, pgs. 46-53
VII. Best Practices and Pitfalls, pgs. 54-56
VIII. Narratives from Interviews, pgs. 57-66
VIIII. Key Findings, pgs. 67-72
X.  Appendix, pgs. 73-78
·	About Best Practices, LLC, pg. 79
List of Charts & Exhibits
·	Disease Awareness (DA) Program Effectiveness
·	Disease Awareness Organizational Structure
·	Functional Involvement & Leadership in DA
·	Presence of Distinct Disease Awareness Group
·	Start and End Point of Disease Awareness Efforts
·	Timing for Disease Awareness Activities
·	Most Heavily Used Disease Awareness Activities
·	Factors Influencing the Amount of Resources Dedicated to Disease Awareness Programs on a Product-by-Product Basis
·	Percentage of Peak-year Sale Projections Spent on the Disease State Awareness Program for a Typical Product Across its Entire Lifecycle
·	Company-Wide Budget for Disease Awareness Initiatives, Activities and Programs
·	Functions Providing Funding for Disease Awareness Programs
·	Peak Investment Year for Disease Awareness Initiatives
·	Percentage of Total Disease Awareness Budget for a New Product Allocated to Different Product Stages
·	Peak Year Investment for Disease Awareness
·	Additional Disease Awareness Investment Needed for Unmet Need Products
·	Importance Level of DA Activities with Advocacy Groups
·	Keys to Developing a Good Relationship with Advocacy
·	Approaches to Support Disease Awareness Activities with Patient Advocacy Groups
·	Timing of Disease Awareness Activities with Patient Advocacy Groups
·	Level of Involvement of the Organization's Legal Department in Different Disease Awareness Program Areas
·	Legal Review Requirements for Key Markets
·	Disease State Awareness (DSA) Social Media Activities
·	Patient Access via Social media
·	Utilization Ranking of Social Media Activities
·	Social Media Spend for Disease Awareness
·	Social Media DA Spend and Percentage of DA Budget
·	Best Practices for Maintaining An Effective Disease State Awareness Program
·	Pitfalls To An Effective Disease Awareness Program